Published in J Immunol on August 15, 1992
Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med (1993) 4.80
An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J Exp Med (1994) 3.47
NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function. J Exp Med (1995) 2.43
In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset. J Exp Med (1993) 2.39
Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ IL-7R+ Thy1+ lympho-hemopoietic progenitors develop. J Exp Med (1996) 2.06
Cytotoxicity of fresh NK1.1+ T cell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target. J Exp Med (1994) 1.60
Human T-cell receptor (TCR) alpha/beta + CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR V beta-gene families, and phenotypically resemble memory T cells. Proc Natl Acad Sci U S A (1993) 1.32
CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells. J Exp Med (1994) 1.19
Occurrence of interleukin-5 production by CD4- CD8- (double-negative) T cells in lungs of both normal and congenitally athymic nude mice infected with Toxocara canis. Immunology (1995) 0.95
Similar rates of production of T and B lymphocytes in the bone marrow. J Exp Med (1995) 0.90
Definition of unique traits of human CD4-CD8- alpha beta T cells. Clin Exp Immunol (1993) 0.82
Human alpha beta T-cell receptor CD4-CD8 T-cell clones are predominantly Th0-like. Immunology (1995) 0.80
Combined approaches for drug design points the way to novel proline racemase inhibitor candidates to fight Chagas' disease. PLoS One (2013) 0.77
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci U S A (2001) 33.71
Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55
Dideoxy sequencing method using denatured plasmid templates. Anal Biochem (1986) 17.34
Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res (2001) 15.22
A physical map of the human genome. Nature (2001) 12.39
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity (1999) 12.36
Genome sequence of the endocellular bacterial symbiont of aphids Buchnera sp. APS. Nature (2000) 11.64
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science (2001) 8.31
Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites. Proc Natl Acad Sci U S A (2001) 4.56
Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol (1998) 4.14
The RCC1 protein, a regulator for the onset of chromosome condensation locates in the nucleus and binds to DNA. J Cell Biol (1989) 4.13
DNA sequence and comparative analysis of chimpanzee chromosome 22. Nature (2004) 4.12
Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci U S A (1999) 3.43
Prospective randomized pilot trial of selective biliary cannulation using pancreatic guide-wire placement. Endoscopy (2003) 3.24
TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol (1985) 3.18
Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. J Biol Chem (2000) 3.11
The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science (1986) 3.09
Classification criteria for polymyositis and dermatomyositis. J Rheumatol (1995) 3.08
Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc (1975) 3.01
NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J (2001) 2.94
A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem (2001) 2.80
Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol (2001) 2.68
L1 family of repetitive DNA sequences in primates may be derived from a sequence encoding a reverse transcriptase-related protein. Nature (1986) 2.66
Complete nucleotide sequences of 93-kb and 3.3-kb plasmids of an enterohemorrhagic Escherichia coli O157:H7 derived from Sakai outbreak. DNA Res (1998) 2.43
Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg (1984) 2.39
Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. Nucleic Acids Res (2000) 2.16
On the heterogeneity of murine natural killer cells. J Exp Med (1981) 2.15
Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol Cell Biol (2000) 2.14
Sequence analysis of a KpnI family member near the 3' end of human beta-globin gene. Nucleic Acids Res (1985) 2.07
Correlation of serum IgG antibodies to recombinant P0 fusion protein with IgG antibodies to carboxyl-terminal 22 synthetic peptides and carboxyl-terminal 22 amino acid-deleted recombinant P0 fusion protein in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.06
Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc (1979) 1.99
Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol (1998) 1.97
The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev (1999) 1.95
Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol (1993) 1.93
Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion. J Biol Chem (1999) 1.86
Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med (1979) 1.81
Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL. Arterioscler Thromb Vasc Biol (2001) 1.78
Complete nucleotide sequence of the prophage VT2-Sakai carrying the verotoxin 2 genes of the enterohemorrhagic Escherichia coli O157:H7 derived from the Sakai outbreak. Genes Genet Syst (1999) 1.70
Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. Int Immunol (1996) 1.68
A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J Biol Chem (1999) 1.68
ALS in Rochester, Minnesota, 1925-1977. Neurology (1980) 1.67
Enumeration of activated thymus-derived lymphocytes by the virus plaque assay. Proc Natl Acad Sci U S A (1973) 1.67
Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc Natl Acad Sci U S A (1998) 1.66
Alkaline phosphatase fusions of ligands or receptors as in situ probes for staining of cells, tissues, and embryos. Methods Enzymol (2000) 1.66
Mode of regulation of natural killer cell activity by interferon. J Exp Med (1980) 1.63
Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem (2000) 1.61
Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J Biol Chem (1989) 1.60
Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon. J Clin Invest (1986) 1.60
Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens. J Immunol (2001) 1.59
Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (1981) 1.59
Central pontine myelinolysis and its imitators: MR findings. Radiology (1988) 1.58
Measures to prevent TRALI. Vox Sang (2007) 1.58
Vertebral-basilar distribution infarction following chiropractic cervical manipulation. Mayo Clin Proc (1980) 1.58
Multiple sclerosis in Rochester, Minn. A 60-year appraisal. Arch Neurol (1971) 1.58
Intracranial dural arteriovenous malformations. Radiology (1972) 1.57
C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry (1998) 1.54
Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. Segregate expression profiles from a rap1GAP gene product. J Biol Chem (1997) 1.54
Meningeal carcinomatosis. Clinical manifestations. Arch Neurol (1974) 1.54
Intracranial germ cell tumors: pathobiological and immunohistochemical aspects of 70 cases. J Neuropathol Exp Neurol (1985) 1.52
Processing of nux vomica. II. Changes in alkaloid composition of the seeds of Strychnos nux-vomica on traditional drug-processing. Chem Pharm Bull (Tokyo) (1990) 1.52
Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1. Gene (2001) 1.51
Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol (1987) 1.51
The human and mouse Period1 genes: five well-conserved E-boxes additively contribute to the enhancement of mPer1 transcription. Genomics (2000) 1.51
The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J Biol Chem (2001) 1.50
Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem (2001) 1.48
The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines. J Exp Med (1973) 1.47
Thiolactomycin, a new antibiotic. IV. Biological properties and chemotherapeutic activity in mice. J Antibiot (Tokyo) (1982) 1.46
Assessment of disease activity in rheumatoid arthritis using magnetic resonance imaging: quantification of pannus volume in the hands. Br J Rheumatol (1998) 1.45
Angiographically occult vascular malformations: a correlative study of features on magnetic resonance imaging and histological examination. Neurosurgery (1994) 1.45
Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli. Biochem Biophys Res Commun (1983) 1.44
4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem (1999) 1.44
Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer. Nature (1997) 1.42
Isolated medulla oblongata function after severe traumatic brain injury. J Neurol Neurosurg Psychiatry (2001) 1.42
The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol (1986) 1.42
L-arginine inhibits neointimal formation following balloon injury. Life Sci (1993) 1.41
Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol (1991) 1.39
Hereditary form of parkinsonism--dementia. Ann Neurol (1998) 1.39
Necrotizing angiopathic neuropathy. Three-dimensional morphology of fiber degeneration related to sites of occluded vessels. Mayo Clin Proc (1972) 1.37
Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med (1985) 1.37
Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun (2001) 1.36
Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol (1998) 1.36
Natural history of stroke in Rochester, Minnesota, 1955 through 1969: an extension of a previous study, 1945 through 1954. Stroke (1973) 1.35
Identification of an internal cis-element essential for the human L1 transcription and a nuclear factor(s) binding to the element. Nucleic Acids Res (1992) 1.35
Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice. Proc Natl Acad Sci U S A (1981) 1.34
Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action. Biochem Biophys Res Commun (1995) 1.33
The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways. Biochem J (1999) 1.32
Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen. J Immunol (2001) 1.32
Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice. J Exp Med (2000) 1.32
Keratinolytic proteinase produced by Candida albicans. Sabouraudia (1984) 1.31
Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity. J Antibiot (Tokyo) (1982) 1.31
Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine (1994) 1.30